Oligometastatic Prostate Cancer Clinical Trials in Saint-Herblain
2 recruitingSaint-Herblain, France
Showing 1–2 of 2 trials
Recruiting
Phase 3
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Oligometastatic Prostate Cancer (OMPC)
Novartis Pharmaceuticals450 enrolled147 locationsNCT05939414
Recruiting
Not Applicable
HIghly MetAstatic Life Prolonging Therapy-Resistant Prostate Cancer: Role of Stereotactic Radiotherapy for Bone and Lymph Node Metastases (HIMARS)
Oligometastatic Prostate Cancer (OMPC)Prostate Cancer Metastatic Disease
Institut Cancerologie de l'Ouest18 enrolled1 locationNCT06978296